This is an open label, intra-patient dose escalation, to evaluate ADI-PEG 20, in combination with Temozolomide (TMZ) and radiation therapy (RT) in children, ad…

GlioblastomaHigh-Grade Glioma (WHO III-IV)High-grade Glioma+2 more

~Estimated

~$10 – $7,500

Sabine Mueller, MD, PhDNCT07389278

Phase 2

Prospective, Single Group, Open-label Multicenter Phase 2 Study With Single-dose Administration of the Optical Imaging Agent FG001 in Subjects With Newly Diagnosed High Grade Glioma Scheduled for Neurosurgical Tumor Resection Under NIR Fluorescence Guidance

This clinical trial aims to determine if FG001 can assist surgeons in identifying the difference between tumor and healthy tissue during surgery in participant…

High-Grade Glioma (WHO III-IV)

~Estimated

~$10 – $7,500

FluoGuide A/SNCT07609472